Therapeutic drug monitoring: no effect on treatment success with nevirapine

This article is more than 19 years old. Click here for more recent articles on this topic

Monitoring drug levels of nevirapine in the blood and providing this information to doctors and patients has not resulted in improved treatment outcomes for Dutch patients, according to a report in the June 1st edition of the Journal of Acquired Immune Deficiency Syndromes.

Dutch researchers looked at 45 patients receiving nevirapine within the ATHENA study, a national observational cohort. They compared treatment outcomes, toxicity and pharmacokinetics in 24 patients who received results of therapeutic drug monitoring tests, and a control group of 21 patients who underwent therapeutic drug monitoring without receiving the results.

Blood was sampled four and 12 weeks after starting treatment, and then every 12 weeks. Researchers compared rates of treatment discontinuation and the proportion of patients with viral load below 500 copies/ml.

Glossary

therapeutic drug monitoring (TDM)

The measurement of plasma drug concentrations in an effort to provide the most effective dosage with the least possible side-effects; TDM can help guide decisions regarding changes in drug dosing.

concentration (of a drug)

The level of a drug in the blood or other body fluid or tissue.

toxicity

Side-effects.

p-value

The result of a statistical test which tells us whether the results of a study are likely to be due to chance and would not be confirmed if the study was repeated. All p-values are between 0 and 1; the most reliable studies have p-values very close to 0. A p-value of 0.001 means that there is a 1 in 1000 probability that the results are due to chance and do not reflect a real difference. A p-value of 0.05 means there is a 1 in 20 probability that the results are due to chance. When a p-value is 0.05 or below, the result is considered to be ‘statistically significant’. Confidence intervals give similar information to p-values but are easier to interpret. 

observational study

A study design in which patients receive routine clinical care and researchers record the outcome. Observational studies can provide useful information but are considered less reliable than experimental studies such as randomised controlled trials. Some examples of observational studies are cohort studies and case-control studies.

Although significantly less variation in nevirapine concentration was noted over time in the unblinded TDM group (p=0.02), there was no difference after 24 months between the groups in the proportion who had discontinued nevirapine treatment (21% vs 19%), in the time to nevirapine discontinuation nor in the proportions with viral load below 500 copies at months 6, 12, 24 or 36.

The authors suggest that nevirapine may not be an appropriate candidate for therapeutic drug monitoring because the variability in concentrations of the drug is much less than for protease inhibitors, except in cases where drug-drug interactions are suspected.

References

Crommentuyn KM et al. Therapeutic drug monitoring of nevirapine reduces pharmacokinetic variability but does not affect toxicity or virologic success in the ATHENA study. J Aquir Immune Defic Syndr 39: 249-250, 2005.